Isoindolines, method of use, and pharmaceutical compositions
US6555554B2 · kind B2 · utility
133Cited by
33References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2001 |
| Grant date | Apr 29, 2003 |
| Priority date | — |
| Expiry date | Feb 12, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines are useful in reducing undesirable levels of TNF&agr; in a mammal. Typical embodiments are pharmaceutical compositions containing 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline and 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4-aminoisoindoline.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.